Clinical Recommendations and Statements from the NPF Medical Board

The Medical Board of the National Psoriasis Foundation (NPF) exists to improve and guide the standard of care for psoriatic disease. The Medical Board serves to evaluate emerging data and publish information for the psoriatic disease community related to the establishment of guidelines, best practices, and position statements related to policy and research.

The following clinical recommendations and statements cover a variety of topics related to the care of individuals living with psoriatic disease including vaccination, biosimilars, cannabis, telemedicine, non-medical switching, and patient management.

Clinical Guidelines

  • Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84(2):432-470. doi:10.1016/j.jaad.2020.07.087
  • Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029-1072. doi:10.1016/j.jaad.2018.11.057
  • Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073-1113. doi:10.1016/j.jaad.2018.11.058
  • Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis. 2019;4(1):31-58. doi:10.1177/2475530318812244

Medical Board Clinical Statements

  • Chat VS, Ellebrecht CT, Kingston P, et al. Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. Published online February 6, 2024. doi:10.1016/j.jaad.2023.12.070  
  • Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019;81(1):102-10 doi:10.1016/j.jaad.2019.03.017

Medical Board Position Statements

  • Armstrong A, Callis-Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, Gladman D, Han G, Hawkes JE, Hsu S, Kircik L, Koo J, Kreuger GG, Lebwohl M, Leonardi C, Lewitt GM, Liao W, Liu C, Markenson J, Merola JF, Orbai A, Prussick R, Richardson V, Soung J, Van Voorhees AS, Wallace E, Weinberg J, Wine Lee L, Harris J, Koons S, Howard L. Position Statement on the Use of Biosimilars for Psoriasis and Psoriatic Arthritis. National Psoriasis Foundation. 2023. https://www.psoriasis.org/position-statement-on-biosimilars/
  • Armstrong A, Lebwohl M, Merola JF, Koons S, Fried R, Hawkes J, et al. Non-Medical Switching Impact on Patients and Providers – Psoriatic Disease Community Taking a Stand. Journal of Psoriasis and Psoriatic Arthritis. 2021:24755303211024205 doi:10.1177/24755303211024205
  • Pelet Del Toro N, Yahia R, Feldman SR, Van Voorhees A, Green L, Schwartzman S, Siegel E, Cordoro KM, Desai SR, Kircik L, Liao W, Hawkes JE, Weinberg J, Koo J, Wallace EB, Howard LM, Armstrong A, Han G. National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine. JAAD Int. 2023 Apr 5;12:32-36. doi:10.1016/j.jdin.2023.02.018

Medical Board Research Statements

  • Hackley M, Thampy D, Waseh S, et al. Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation. J Am Acad Dermatol. 2024;90(2):408-410. doi:10.1016/j.jaad.2023.09.078
  • Nussbaum D, Desai S, Gonzalez-Lopez A, Hawkes JE, Gondo G, Friedman A. Practices and perspectives on medical cannabis and cannabinoids: A Survey of the National Psoriasis Foundation Medical Advisory Board. JAAD Int. 2022. doi:10.1016/j.jdin.2022.07.001

Get the Latest for Psoriatic Disease Professionals

Join our email list for medical professionals and researchers to stay up-to-date and get the latest information on psoriatic disease.

Sign up

Journal of Psoriasis and Psoriatic Arthritis®

NPF publishes the latest research for dermatologists, rheumatologists, and the community in the Journal of Psoriasis and Psoriatic Arthritis®.

Learn more

NPF-Led Research and Publications

Learn more about NPF-led research through the complete collection of publications that NPF staff and partners have contributed to.

View the NPF-led publications

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.